Patents Assigned to JIANGSU QYUNS THERAPEUTICS CO., LTD.
  • ANTI-HUMAN INTERLEUKIN 17A MONOCLONAL ANTIBODY AND APPLICATION THEREOF
    Publication number: 20210230264
    Abstract: Disclosed by the present invention are an anti-human interleukin 17A monoclonal antibody and an application thereof. The epitope of the monoclonal antibody binding to human interleukin 17A comprises 78th asparagine (N78). The antibody may be used to treat rheumatoid arthritis, psoriasis, multiple sclerosis, psoriatic arthritis, plaque psoriasis and/or ankylosing spondylitis.
    Type: Application
    Filed: May 17, 2018
    Publication date: July 29, 2021
    Applicant: JIANGSU QYUNS THERAPEUTICS CO., LTD.
    Inventors: Jiwan QIU, Zhihua QIU, Wei CHEN, Tao CHEN, Yong KONG, Yiliang WU